The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Furin‐Mediated Sequential Delivery of Anticancer Cytokine and Small‐Molecule Drug Shuttled by Graphene
Open accessAbstract
A cellular protease (furin)-mediated graphene-based nanosystem is developed for co-delivery of a membrane-associated cytokine (tumor-necrosis-factor-related apoptosis-inducing ligand, TRAIL) and an intracellular-acting small-molecule drug (Doxorubicin, DOX). TRAIL and DOX can be sequentially released toward the plasma membrane and nucleus, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Combinatorial drug therapy for cancer in the post-genomic era
Al-Lazikani, B., Banerji, U., & Workman, P. (2012) · Nature Biotechnology · doi:10.1038/nbt.2284 · Cited by 1,070
Cited by
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Lu, Y., Aimetti, A. A., Langer, R., & Gu, Z. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.75 · Cited by 1,421
Self-citationAnticancer Platelet‐Mimicking Nanovehicles
Hu, Q., Sun, W., Qian, C., Wang, C., Bomba, H. N., & Gu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201503323 · Cited by 630
Self-citationRecent advances of cocktail chemotherapy by combination drug delivery systems
Hu, Q., Sun, W., Wang, C., & Gu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.022 · Cited by 625
Self-citationElectrospun polymer biomaterials
Ding, J., Zhang, J., Li, J., Li, D., Xiao, C., Xiao, H., Yang, H., Zhuang, X., & Chen, X. (2019) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2019.01.002 · Cited by 605
Two‐Dimensional Nanomaterials for Photothermal Therapy
Liu, S., Pan, X., & Liu, H. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201911477 · Cited by 592
Nanocarbons for Biology and Medicine: Sensing, Imaging, and Drug Delivery
Panwar, N., Soehartono, A. M., Chan, K. K., Zeng, S., Xu, G., Qu, J., Coquet, P., Yong, K.-T., & Chen, X. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00099 · Cited by 555
Tao, W., Ji, X., Xu, X., Islam, M. A., Li, Z., Chen, S., Saw, P. E., Zhang, H., Bharwani, Z., Guo, Z., et al. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201703657 · Cited by 526
Applications of π-π stacking interactions in the design of drug-delivery systems
Zhuang, W.-R., Wang, Y., Cui, P.-F., Xing, L., Lee, J., Kim, D., Jiang, H.-L., & Oh, Y.-K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.014 · Cited by 508
External triggering and triggered targeting strategies for drug delivery
Wang, Y., & Kohane, D. S. (2017) · Nature Reviews Materials · doi:10.1038/natrevmats.2017.20 · Cited by 418
Stimuli responsive drug delivery systems based on nano-graphene for cancer therapy
Yang, K., Feng, L., & Liu, Z. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.015 · Cited by 415
Nanotechnology for protein delivery: Overview and perspectives
Yu, M., Wu, J., Shi, J., & Farokhzad, O. C. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.012 · Cited by 410
Two‐Dimensional Antimonene‐Based Photonic Nanomedicine for Cancer Theranostics
Tao, W., Ji, X., Zhu, X., Li, L., Wang, J., Zhang, Y., Saw, P. E., Li, W., Kong, N., Islam, M. A., et al. (2018) · Advanced Materials · doi:10.1002/adma.201802061 · Cited by 388
Tumor microenvironment and intracellular signal-activated nanomaterials for anticancer drug delivery
Mo, R., & Gu, Z. (2016) · Materials Today · doi:10.1016/j.mattod.2015.11.025 · Cited by 381
Self-citationRecent Advances in Subcellular Targeted Cancer Therapy Based on Functional Materials
Chen, W., Luo, G., & Zhang, X. (2019) · Advanced Materials · doi:10.1002/adma.201802725 · Cited by 373
Graphene‐Based Smart Platforms for Combined Cancer Therapy
Gu, Z., Zhu, S., Yan, L., Zhao, F., & Zhao, Y. (2019) · Advanced Materials · doi:10.1002/adma.201800662 · Cited by 334
Self-citationA Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy
Mu, W., Chu, Q., Liu, Y., & Zhang, N. (2020) · Nano-Micro Letters · doi:10.1007/s40820-020-00482-6 · Cited by 328
Inorganic nanoparticles: A potential cancer therapy for human welfare
Pugazhendhi, A., Edison, T. N. J. I., Karuppusamy, I., & Kathirvel, B. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.01.034 · Cited by 325
Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy
Zhai, Y., Su, J., Ran, W., Zhang, P., Yin, Q., Zhang, Z., Yu, H., & Li, Y. (2017) · Theranostics · doi:10.7150/thno.20118 · Cited by 312
Jiang, T., Wang, T., Li, T., Ma, Y., Shen, S., He, B., & Mo, R. (2018) · ACS Nano · doi:10.1021/acsnano.8b03800 · Cited by 278
Self-citationRecent Advances in Photoacoustic Imaging for Deep-Tissue Biomedical Applications
Wang, S., Lin, J., Wang, T., Chen, X., & Huang, P. (2016) · Theranostics · doi:10.7150/thno.16715 · Cited by 261
Nanoformulations for combination or cascade anticancer therapy
Miao, L., Guo, S., Lin, C. M., Liu, Q., & Huang, L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.06.003 · Cited by 178
“In addition to the design of ratiometric loading and delivery, NPs can also be designed for cascade, sequentially [95] or spatiotemporally controlled release [81, 94] and stimuli-responsive properties [80, 96–98] based on different therapeutic purposes.”
BackgroundLeveraging Physiology for Precision Drug Delivery
Sun, W., Hu, Q., Ji, W., Wright, G., & Gu, Z. (2017) · Physiological Reviews · doi:10.1152/physrev.00015.2016 · Cited by 169
Self-citationOpportunities and challenges in combination gene cancer therapy
Nastiuk, K. L., & Krolewski, J. J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.005 · Cited by 85
Zhao, B., Dong, K., Lin, M., Dong, G., Shan, S., Lawson, T., Yan, L., Zhang, W., Shi, B., Chou, S., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800377 · Cited by 18
Metadata
- Authors
- Jiang, T., Sun, W., Zhu, Q., Burns, N. A., Khan, S. A., Mo, R., & Gu, Z.
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2014-12-15
- Volume
- 27
- Issue
- 6
- Pages
- 1021-1028
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W2109552892
- Cited by
- 227
- References
- 2
- FWCI
- 10.59
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.